| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 10 |
| NetGPI | no | yes: 0, no: 10 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005730 | nucleolus | 5 | 1 |
| GO:0043226 | organelle | 2 | 1 |
| GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
| GO:0043229 | intracellular organelle | 3 | 1 |
| GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AG47
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 159 | 163 | PF00656 | 0.616 |
| CLV_NRD_NRD_1 | 168 | 170 | PF00675 | 0.700 |
| CLV_NRD_NRD_1 | 172 | 174 | PF00675 | 0.692 |
| CLV_PCSK_FUR_1 | 146 | 150 | PF00082 | 0.551 |
| CLV_PCSK_KEX2_1 | 148 | 150 | PF00082 | 0.481 |
| CLV_PCSK_PC1ET2_1 | 148 | 150 | PF00082 | 0.479 |
| CLV_PCSK_SKI1_1 | 124 | 128 | PF00082 | 0.520 |
| CLV_PCSK_SKI1_1 | 2 | 6 | PF00082 | 0.372 |
| CLV_PCSK_SKI1_1 | 92 | 96 | PF00082 | 0.526 |
| DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.409 |
| DOC_PP1_RVXF_1 | 22 | 28 | PF00149 | 0.525 |
| DOC_PP2B_LxvP_1 | 73 | 76 | PF13499 | 0.446 |
| DOC_USP7_MATH_1 | 126 | 130 | PF00917 | 0.624 |
| DOC_USP7_MATH_1 | 37 | 41 | PF00917 | 0.482 |
| DOC_USP7_MATH_1 | 82 | 86 | PF00917 | 0.719 |
| DOC_USP7_UBL2_3 | 124 | 128 | PF12436 | 0.542 |
| DOC_USP7_UBL2_3 | 170 | 174 | PF12436 | 0.634 |
| DOC_WW_Pin1_4 | 44 | 49 | PF00397 | 0.564 |
| LIG_14-3-3_CanoR_1 | 116 | 120 | PF00244 | 0.592 |
| LIG_14-3-3_CanoR_1 | 92 | 99 | PF00244 | 0.579 |
| LIG_BRCT_BRCA1_1 | 85 | 89 | PF00533 | 0.570 |
| LIG_CSL_BTD_1 | 25 | 28 | PF09270 | 0.442 |
| LIG_FHA_1 | 67 | 73 | PF00498 | 0.548 |
| LIG_FHA_2 | 12 | 18 | PF00498 | 0.555 |
| LIG_FHA_2 | 93 | 99 | PF00498 | 0.503 |
| LIG_LIR_Nem_3 | 52 | 58 | PF02991 | 0.437 |
| LIG_SH3_3 | 162 | 168 | PF00018 | 0.600 |
| LIG_SUMO_SIM_par_1 | 69 | 78 | PF11976 | 0.434 |
| MOD_CK1_1 | 129 | 135 | PF00069 | 0.641 |
| MOD_CK1_1 | 47 | 53 | PF00069 | 0.577 |
| MOD_CK1_1 | 85 | 91 | PF00069 | 0.558 |
| MOD_CK2_1 | 161 | 167 | PF00069 | 0.743 |
| MOD_GlcNHglycan | 128 | 131 | PF01048 | 0.638 |
| MOD_GlcNHglycan | 51 | 54 | PF01048 | 0.574 |
| MOD_GlcNHglycan | 85 | 88 | PF01048 | 0.580 |
| MOD_GSK3_1 | 115 | 122 | PF00069 | 0.543 |
| MOD_PKA_2 | 115 | 121 | PF00069 | 0.536 |
| MOD_Plk_1 | 161 | 167 | PF00069 | 0.588 |
| MOD_Plk_4 | 11 | 17 | PF00069 | 0.467 |
| MOD_Plk_4 | 161 | 167 | PF00069 | 0.585 |
| MOD_ProDKin_1 | 44 | 50 | PF00069 | 0.562 |
| MOD_SUMO_for_1 | 147 | 150 | PF00179 | 0.521 |
| MOD_SUMO_rev_2 | 167 | 176 | PF00179 | 0.662 |
| MOD_SUMO_rev_2 | 59 | 65 | PF00179 | 0.333 |
| TRG_ENDOCYTIC_2 | 55 | 58 | PF00928 | 0.393 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1IJ04 | Leptomonas seymouri | 65% | 98% |
| A0A0S4INX7 | Bodo saltans | 40% | 90% |
| A0A1X0P8U1 | Trypanosomatidae | 38% | 91% |
| A0A3S5H549 | Leishmania donovani | 100% | 100% |
| A0A422NMF6 | Trypanosoma rangeli | 40% | 95% |
| A4H3M0 | Leishmania braziliensis | 87% | 100% |
| D0A262 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 35% | 79% |
| E9ACK3 | Leishmania major | 95% | 100% |
| E9AJU1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |